NCT05517811View on ClinicalTrials.gov

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

RecruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

June 26, 2022

Primary Completion Date

May 31, 2028

Study Completion Date

July 31, 2028

Conditions

Liver CancerEsophageal CancerColorectal CancerLung AdenocarcinomaControlPancreas CancerBiliary Cancer

Interventions

DIAGNOSTIC_TEST

TEG indices

Blood samples

Trial Locations (1)

80045

RECRUITING

University of Colorado Denver, Aurora

Sponsors

Collaborators (1)

Haemonetics Corporation

All Listed Sponsors

collaborator

Haemonetics Corporation

INDUSTRY

lead

University of Colorado, Denver

OTHER